The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Engineering Nano‐ and Microparticles to Tune Immunity
Open accessAbstract
The immune system can be a cure or cause of disease, fulfilling a protective role in attacking cancer or pathogenic microbes but also causing tissue destruction in autoimmune disorders. Thus, therapies aimed to amplify or suppress immune reactions are of great interest. However, the complex regulation of the immune system, coupled with the potential systemic side effects associated with traditional systemic drug therapies, has presented a major hurdle for the development of successful immunotherapies. Recent progress in the design of synthetic micro‐ and nano‐particles that can target drugs, deliver imaging agents, or stimulate immune cells directly through their physical and chemical properties is leading to new approaches to deliver vaccines, promote immune responses against tumors, and suppress autoimmunity. In addition, novel strategies, such as the use of particle‐laden immune cells as living targeting agents for drugs, are providing exciting new approaches for immunotherapy. This progress report describes recent advances in the design of micro‐ and nano‐particles for immunotherapies and diagnostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Regulation of Adaptive Immunity by the Innate Immune System
Iwasaki, A., & Medzhitov, R. (2010) · Science · doi:10.1126/science.1183021 · Cited by 2,157
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Jiang, S., & Cao, Z. (2010) · Advanced Materials · doi:10.1002/adma.200901407 · Cited by 2,027
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Holmgren, J., & Czerkinsky, C. (2005) · Nature Medicine · doi:10.1038/nm1213 · Cited by 1,562
Physical approaches to biomaterial design
Mitragotri, S., & Lahann, J. (2009) · Nature Materials · doi:10.1038/nmat2344 · Cited by 1,445
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T Cells
O’Shea, J. J., & Paul, W. E. (2010) · Science · doi:10.1126/science.1178334 · Cited by 1,336
Intracellular Toll-like Receptors
Blasius, A. L., & Beutler, B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.012 · Cited by 1,325
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,206
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Dendritic-cell trafficking to lymph nodes through lymphatic vessels
Randolph, G. J., Angeli, V., & Swartz, M. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1670 · Cited by 1,111
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes
Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,081
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo
Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M., & Muller, W. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80149-1 · Cited by 900
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Junt, T., Moseman, E. A., Iannacone, M., Massberg, S., Lang, P. A., Boes, M., Fink, K., Henrickson, S. E., Shayakhmetov, D. M., Di Paolo, N. C., et al. (2007) · Nature · doi:10.1038/nature06287 · Cited by 846
Dendritic Cells: Translating Innate to Adaptive Immunity
Steinman, R. M., & Hemmi, H. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-32636-7_2 · Cited by 844
Toll-dependent selection of microbial antigens for presentation by dendritic cells
Blander, J. M., & Medzhitov, R. (2006) · Nature · doi:10.1038/nature04596 · Cited by 840
Therapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839
de Vries, I. J. M., Lesterhuis, W. J., Barentsz, J. O., Verdijk, P., van Krieken, J. H., Boerman, O. C., Oyen, W. J. G., Bonenkamp, J. J., Boezeman, J. B., Adema, G. J., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1154 · Cited by 821
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A., & Irvine, D. J. (2010) · Nature Medicine · doi:10.1038/nm.2198 · Cited by 750
Self-citationMaking polymeric micro- and nanoparticles of complex shapes
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705326104 · Cited by 747
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Biphasic Janus particles with nanoscale anisotropy
Roh, K.-H., Martin, D. C., & Lahann, J. (2005) · Nature Materials · doi:10.1038/nmat1486 · Cited by 725
Nisisako, T., Torii, T., Takahashi, T., & Takizawa, Y. (2006) · Advanced Materials · doi:10.1002/adma.200502431 · Cited by 724
Nie, Z., Li, W., Seo, M., Xu, S., & Kumacheva, E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja060882n · Cited by 689
T-cell-antigen recognition and the immunological synapse
Huppa, J. B., & Davis, M. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1245 · Cited by 643
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
Engering, A., Geijtenbeek, T. B. H., van Vliet, S. J., Wijers, M., van Liempt, E., Demaurex, N., Lanzavecchia, A., Fransen, J., Figdor, C. G., Piguet, V., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2118 · Cited by 630
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Carrasco, Y. R., & Batista, F. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.007 · Cited by 617
Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R., & Hanes, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597
A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Self-citationMuro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., Schuchman, E. H., Mitragotri, S., & Muzykantov, V. R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.127 · Cited by 564
Materials engineering for immunomodulation
Hubbell, J. A., Thomas, S. N., & Swartz, M. A. (2009) · Nature · doi:10.1038/nature08604 · Cited by 561
Merkel, T. J., Jones, S. W., Herlihy, K. P., Kersey, F. R., Shields, A. R., Napier, M., Luft, J. C., Wu, H., Zamboni, W. C., Wang, A. Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010013108 · Cited by 548
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
Inducible IL-2 production by dendritic cells revealed by global gene expression analysis
Granucci, F., Vizzardelli, C., Pavelka, N., Feau, S., Persico, M., Virzi, E., Rescigno, M., Moro, G., & Ricciardi-Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/ni0901-882 · Cited by 520
A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy
Cho, N.-H., Cheong, T.-C., Min, J. H., Wu, J. H., Lee, S. J., Kim, D., Yang, J.-S., Kim, S., Kim, Y. K., & Seong, S.-Y. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.149 · Cited by 514
The effects of polymeric nanostructure shape on drug delivery
Venkataraman, S., Hedrick, J. L., Ong, Z. Y., Yang, C., Ee, P. L. R., Hammond, P. T., & Yang, Y. Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.016 · Cited by 510
Tsai, R. K., & Discher, D. E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708043 · Cited by 486
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Nochi, T., Yuki, Y., Takahashi, H., Sawada, S.-I., Mejima, M., Kohda, T., Harada, N., Kong, I. G., Sato, A., Kataoka, N., et al. (2010) · Nature Materials · doi:10.1038/nmat2784 · Cited by 468
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905998106 · Cited by 453
The adhesive strength of non-spherical particles mediated by specific interactions
Decuzzi, P., & Ferrari, M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.024 · Cited by 452
Virgin, H. W., & Levine, B. (2009) · Nature Immunology · doi:10.1038/ni.1726 · Cited by 451
Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W. (2009) · Nature Materials · doi:10.1038/nmat2444 · Cited by 438
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer
Butts, C., Murray, N., Maksymiuk, A., Goss, G., Marshall, E., Soulières, D., Cormier, Y., Ellis, P., Price, A., Sawhney, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.011 · Cited by 428
de Saint-Vis, B., Fugier-Vivier, I., Massacrier, C., Gaillard, C., Vanbervliet, B., Aït-Yahia, S., Banchereau, J., Liu, Y.-J., Lebecque, S., & Caux, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1666 · Cited by 427
B Cell-Driven Lymphangiogenesis in Inflamed Lymph Nodes Enhances Dendritic Cell Mobilization
Angeli, V., Ginhoux, F., Llodrà, J., Quemeneur, L., Frenette, P. S., Skobe, M., Jessberger, R., Merad, M., & Randolph, G. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.003 · Cited by 424
Hattangadi, S. M., Wong, P., Zhang, L., Flygare, J., & Lodish, H. F. (2011) · Blood · doi:10.1182/blood-2011-07-356006 · Cited by 423
Pape, K. A., Catron, D. M., Itano, A. A., & Jenkins, M. K. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.011 · Cited by 391
Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target
Beningo, K. A., & Wang, Y.-L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.4.849 · Cited by 389
THE LIFE SPAN OF THE HUMAN RED BLOOD CELL
Shemin, D., & Rittenberg, D. (1946) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35201-8 · Cited by 385
Red blood cell-mimicking synthetic biomaterial particles
Doshi, N., Zahr, A. S., Bhaskar, S., Lahann, J., & Mitragotri, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907127106 · Cited by 374
T cell stimulation and expansion using anti-CD3/CD28 beads
Trickett, A., & Kwan, Y. L. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00010-3 · Cited by 367
Li, H., Li, Y., Jiao, J., & Hu, H.-M. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.153 · Cited by 347
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., & Bramwell, V. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.036 · Cited by 333
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314
Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
Rosenberg, S. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.116 · Cited by 312
Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T Cells
Tsai, S., Shameli, A., Yamanouchi, J., Clemente-Casares, X., Wang, J., Serra, P., Yang, Y., Medarova, Z., Moore, A., & Santamaria, P. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.015 · Cited by 309
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy
Broaders, K. E., Cohen, J. A., Beaudette, T. T., Bachelder, E. M., & Fréchet, J. M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901592106 · Cited by 308
Characterization of Particle Translocation through Mucin Hydrogels
Lieleg, O., Vladescu, I., & Ribbeck, K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.01.012 · Cited by 306
Gentile, F., Chiappini, C., Fine, D., Bhavane, R. C., Peluccio, M. S., Cheng, M. M.-C., Liu, X., Ferrari, M., & Decuzzi, P. (2008) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2008.03.021 · Cited by 304
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Christian, D. A., Cai, S., Garbuzenko, O. B., Harada, T., Zajac, A. L., Minko, T., & Discher, D. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900022m · Cited by 289
In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287
Self-citationCruz, L. J., Tacken, P. J., Fokkink, R., Joosten, B., Stuart, M. C., Albericio, F., Torensma, R., & Figdor, C. G. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.013 · Cited by 281
Targeting STAT3 affects melanoma on multiple fronts
Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 280
The Receptor-Mediated Endocytosis of Nonspherical Particles
Decuzzi, P., & Ferrari, M. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120238 · Cited by 278
Design of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277
Busse, D., de la Rosa, M., Hobiger, K., Thurley, K., Flossdorf, M., Scheffold, A., & Höfer, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812851107 · Cited by 273
Cu, Y., & Saltzman, W. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp8001254 · Cited by 267
Infectious disease: Connecting innate immunity to biocidal polymers
Gabriel, G. J., Som, A., Madkour, A. E., Eren, T., & Tew, G. N. (2007) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.03.002 · Cited by 264
Schlosser, E., Mueller, M., Fischer, S., Basta, S., Busch, D. H., Gander, B., & Groettrup, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.01.030 · Cited by 262
Nanoparticles and microparticles as vaccine-delivery systems
Singh, M., Chakrapani, A., & O’Hagan, D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.797 · Cited by 259
Belyakov, I. M., Derby, M. A., Ahlers, J. D., Kelsall, B. L., Earl, P., Moss, B., Strober, W., & Berzofsky, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1709 · Cited by 258
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
Dou, H., Destache, C. J., Morehead, J. R., Mosley, R. L., Boska, M. D., Kingsley, J., Gorantla, S., Poluektova, L., Nelson, J. A., Chaubal, M., et al. (2006) · Blood · doi:10.1182/blood-2006-03-012534 · Cited by 253
Bozzacco, L., Trumpfheller, C., Siegal, F. P., Mehandru, S., Markowitz, M., Carrington, M., Nussenzweig, M. C., Piperno, A. G., & Steinman, R. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610383104 · Cited by 247
Jewell, C. M., Bustamante López, S. C., & Irvine, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105200108 · Cited by 245
Self-citationSapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis
Hayder, M., Poupot, M., Baron, M., Nigon, D., Turrin, C.-O., Caminade, A.-M., Majoral, J.-P., Eisenberg, R. A., Fournié, J.-J., Cantagrel, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002212 · Cited by 241
Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
Dinauer, N., Balthasar, S., Weber, C., Kreuter, J., Langer, K., & von Briesen, H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.038 · Cited by 234
Hirosue, S., Kourtis, I. C., van der Vlies, A. J., Hubbell, J. A., & Swartz, M. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.077 · Cited by 233
Belyakov, I. M., Hel, Z., Kelsall, B., Kuznetsov, V. A., Ahlers, J. D., Nacsa, J., Watkins, D. I., Allen, T. M., Sette, A., Altman, J., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1320 · Cited by 232
Mohanan, D., Slütter, B., Henriksen-Lacey, M., Jiskoot, W., Bouwstra, J. A., Perrie, Y., Kündig, T. M., Gander, B., & Johansen, P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.012 · Cited by 229
Zhang, Z., Tongchusak, S., Mizukami, Y., Kang, Y. J., Ioji, T., Touma, M., Reinhold, B., Keskin, D. B., Reinherz, E. L., & Sasada, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.067 · Cited by 228
Kim, Y. H., Gratzinger, D., Harrison, C., Brody, J. D., Czerwinski, D. K., Ai, W. Z., Morales, A., Abdulla, F., Xing, L., Navi, D., et al. (2012) · Blood · doi:10.1182/blood-2011-05-355222 · Cited by 210
Granelli-Piperno, A., Pritsker, A., Pack, M., Shimeliovich, I., Arrighi, J.-F., Park, C. G., Trumpfheller, C., Piguet, V., Moran, T. M., & Steinman, R. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4265 · Cited by 208
Folate‐targeted nanoparticles show efficacy in the treatment of inflammatory arthritis
Thomas, T. P., Goonewardena, S. N., Majoros, I. J., Kotlyar, A., Cao, Z., Leroueil, P. R., & Baker, J. R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30459 · Cited by 208
RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice
Kim, S.-S., Peer, D., Kumar, P., Subramanya, S., Wu, H., Asthana, D., Habiro, K., Yang, Y.-G., Manjunath, N., Shimaoka, M., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.271 · Cited by 207
Surface Functionalization of Living Cells with Multilayer Patches
Swiston, A. J., Cheng, C., Um, S. H., Irvine, D. J., Cohen, R. E., & Rubner, M. F. (2008) · Nano Letters · doi:10.1021/nl802404h · Cited by 204
Self-citationKwon, Y. J., James, E., Shastri, N., & Fréchet, J. M. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509541102 · Cited by 201
Cruz, L. J., Tacken, P. J., Fokkink, R., & Figdor, C. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.082 · Cited by 201
Cell‐Based Drug Delivery Devices Using Phagocytosis‐Resistant Backpacks
Doshi, N., Swiston, A. J., Gilbert, J. B., Alcaraz, M. L., Cohen, R. E., Rubner, M. F., & Mitragotri, S. (2011) · Advanced Materials · doi:10.1002/adma.201004074 · Cited by 191
Shao, K., Huang, R., Li, J., Han, L., Ye, L., Lou, J., & Jiang, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.018 · Cited by 191
Steenblock, E. R., & Fahmy, T. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.11 · Cited by 187
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
Nembrini, C., Stano, A., Dane, K. Y., Ballester, M., van der Vlies, A. J., Marsland, B. J., Swartz, M. A., & Hubbell, J. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104264108 · Cited by 187
A role for the immunological synapse in lineage commitment of CD4 lymphocytes
Maldonado, R. A., Irvine, D. J., Schreiber, R., & Glimcher, L. H. (2004) · Nature · doi:10.1038/nature02916 · Cited by 181
Self-citationSynchrony of High Endothelial Venules and Lymphatic Vessels Revealed by Immunization
Liao, S., & Ruddle, N. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3369 · Cited by 180
Kwong, B., Liu, H., & Irvine, D. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.067 · Cited by 175
Self-citationSexton, A., Whitney, P. G., Chong, S.-F., Zelikin, A. N., Johnston, A. P. R., De Rose, R., Brooks, A. G., Caruso, F., & Kent, S. J. (2009) · ACS Nano · doi:10.1021/nn900715g · Cited by 173
Pang, Z., Feng, L., Hua, R., Chen, J., Gao, H., Pan, S., Jiang, X., & Zhang, P. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100277h · Cited by 156
Rose, R. D., Zelikin, A. N., Johnston, A. P. R., Sexton, A. L., Chong, S., Cortez‐Jugo, C., Mulholland, W. J., Caruso, F., & Kent, S. J. (2008) · Advanced Materials · doi:10.1002/adma.200801826 · Cited by 154
Carrillo‐Conde, B., Song, E.-H., Chavez-Santoscoy, A. V., Phanse, Y., Ramer‐Tait, A. E., Pohl, N. L. B., Wannemuehler, M. J., Bellaire, B. H., & Narasimhan, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200213r · Cited by 147
Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery
Cheng, H., Kastrup, C. J., Ramanathan, R., Siegwart, D. J., Ma, M., Bogatyrev, S. R., Xu, Q., Whitehead, K. A., Langer, R., & Anderson, D. G. (2010) · ACS Nano · doi:10.1021/nn901319y · Cited by 146
The impact of nanoparticle ligand density on dendritic-cell targeted vaccines
Bandyopadhyay, A., Fine, R. L., Demento, S., Bockenstedt, L. K., & Fahmy, T. M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.054 · Cited by 141
Ulery, B. D., Kumar, D., Ramer‐Tait, A. E., Metzger, D. W., Wannemuehler, M. J., & Narasimhan, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017642 · Cited by 137
Sokolova, V., Knuschke, T., Kovtun, A., Buer, J., Epple, M., & Westendorf, A. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.067 · Cited by 136
Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity
Heit, A., Schmitz, F., Haas, T. L., Busch, D. H., & Wagner, H. (2007) · European Journal of Immunology · doi:10.1002/eji.200737169 · Cited by 136
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma
Tagawa, S. T., Lee, P. P., Snively, J., Boswell, W. D., Ounpraseuth, S., Lee, S., Hickingbottom, B., Smith, J. W., Johnson, D. L., & Weber, J. S. (2003) · Cancer · doi:10.1002/cncr.11462 · Cited by 134
NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens
Brodsky, I. E., & Monack, D. M. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.007 · Cited by 134
Uto, T., Akagi, T., Yoshinaga, K., Toyama, M., Akashi, M., & Baba, M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.052 · Cited by 130
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
Cu, Y., Booth, C. J., & Saltzman, W. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.036 · Cited by 129
New Therapies for Castration-Resistant Prostate Cancer
Longo, D. L. (2010) · New England Journal of Medicine · doi:10.1056/nejme1006300 · Cited by 128
Engineering complement activation on polypropylene sulfide vaccine nanoparticles
Thomas, S. N., van der Vlies, A. J., O’Neil, C. P., Reddy, S. T., Yu, S. S., Giorgio, T. D., Swartz, M. A., & Hubbell, J. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.037 · Cited by 127
Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases
van Ginkel, F. W., Nguyen, H. H., & McGhee, J. R. (2000) · Emerging infectious diseases · doi:10.3201/eid0602.000204 · Cited by 125
Tosi, G., Vergoni, A. V., Ruozi, B., Bondioli, L., Badiali, L., Rivasi, F., Costantino, L., Forni, F., & Vandelli, M. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.008 · Cited by 124
Primard, C., Rochereau, N., Luciani, E., Genin, C., Delair, T., Paul, S., & Verrier, B. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.021 · Cited by 122
T cells enhance gold nanoparticle delivery to tumors in vivo
Kennedy, L. C., Bear, A. S., Young, J. K., Lewinski, N. A., Kim, J., Foster, A. E., & Drezek, R. A. (2011) · Nanoscale Research Letters · doi:10.1186/1556-276x-6-283 · Cited by 121
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
Kazzaz, J., Singh, M., Ugozzoli, M., Chesko, J., Soenawan, E., & O’Hagan, D. T. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.010 · Cited by 120
Demento, S. L., Bonafé, N., Cui, W., Kaech, S. M., Caplan, M. J., Fikrig, E., Ledizet, M., & Fahmy, T. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000768 · Cited by 120
Foster, S., Duvall, C. L., Crownover, E. F., Hoffman, A. S., & Stayton, P. S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100204m · Cited by 120
Ishikawa-Sekigami, T., Kaneko, Y., Okazawa, H., Tomizawa, T., Okajo, J., Saito, Y., Okuzawa, C., Sugawara-Yokoo, M., Nishiyama, U., Ohnishi, H., et al. (2005) · Blood · doi:10.1182/blood-2005-05-1896 · Cited by 119
Alshamsan, A., Hamdy, S. I., Samuel, J., El‐Kadi, A. O. S., Lavasanifar, A., & Uludağ, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.003 · Cited by 114
Activation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles
Hamdy, S. I., Haddadi, A., Shayeganpour, A., Samuel, J., & Lavasanifar, A. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0459-9 · Cited by 113
Steenblock, E. R., Fadel, T. R., Labowsky, M. J., Pober, J. S., & Fahmy, T. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276329 · Cited by 113
Park, J. Y., Gao, W., Whiston, R., Strom, T. B., Metcalfe, S. M., & Fahmy, T. M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100203a · Cited by 109
Xie, H., Gürsel, İ., Ivins, B. E., Singh, M., O’Hagan, D. T., Ulmer, J. B., & Klinman, D. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.828-833.2005 · Cited by 109
Immunotherapy for the treatment of prostate cancer
Lorenzo, G. D., Buonerba, C., & Kantoff, P. W. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.72 · Cited by 104
Cui, L., Cohen, J. A., Broaders, K. E., Beaudette, T. T., & Fréchet, J. M. J. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100596w · Cited by 103
Kratky, W., Sousa, C. R. E., Oxenius, A., & Spörri, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108945108 · Cited by 101
Koker, S. D., Naessens, T., Geest, B. G. D., Bogaert, P., Demeester, J., Smedt, S. C. D., & Grooten, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803591 · Cited by 100
Particle Shape: A New Design Parameter for Passive Targeting In Splenotropic Drug Delivery
Devarajan, P. V., Jindal, A. B., Patil, R. R., Mulla, F., Gaikwad, R. V., & Samad, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22052 · Cited by 96
Design of bio-mimetic particles with enhanced vascular interaction
Lee, S., Mauro Ferrari, B., & Decuzzi, P. (2009) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.05.012 · Cited by 95
Nordly, P., Rose, F., Christensen, D., Nielsen, H. M., Andersen, P. L., Agger, E. M., & Foged, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.021 · Cited by 93
Polymer-supported lipid shells, onions, and flowers
Bershteyn, A., Chaparro, J., Yau, R. G., Kim, M., Reinherz, E. L., Moita, L. F., & Irvine, D. J. (2008) · Soft Matter · doi:10.1039/b804933e · Cited by 92
Self-citationPolylactide‐cyclosporin A nanoparticles for targeted immunosuppression
Azzi, J. R., Tang, L., Moore, R. F., Tong, R., Haddad, N. E., Akiyoshi, T., Mfarrej, B. G., Yang, S., Jurewicz, M. M., Ichimura, T., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-154690 · Cited by 89
Flanary, S., Hoffman, A. S., & Stayton, P. S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800317a · Cited by 87
Slütter, B., & Jiskoot, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.009 · Cited by 86
Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response
Noh, Y., Jang, Y., Ahn, K. J., Lim, Y. T., & Chung, B. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.013 · Cited by 83
Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles
Ghotbi, Z., Haddadi, A., Hamdy, S. I., Hung, R., Samuel, J., & Lavasanifar, A. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.499463 · Cited by 81
Schweingruber, N., Haine, A., Tiede, K., Karabinskaya, A., van den Brandt, J., Wüst, S., Metselaar, J. M., Gold, R., Tuckermann, J. P., Reichardt, H. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101604 · Cited by 76
Enhancement of Anti-Tumor Immunity Through Local Modulation of CTLA-4 and GITR by Dendritic Cells
Pruitt, S. K., Boczkowski, D., de Rosa, N., Haley, N. R., Morse, M. A., Tyler, D. S., Dannull, J., & Nair, S. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201141383 · Cited by 76
Nanoscale Particle Therapies for Wounds and Ulcers
Cortivo, R., Vindigni, V., Iacobellis, L., Abatangelo, G., Pinton, P., & Zavan, B. (2010) · Nanomedicine · doi:10.2217/nnm.10.32 · Cited by 76
Hu, Y., Atukorale, P. U., Lu, J. J.-Q., Moon, J. J., Um, S. H., Cho, E. C., Wang, Y., Chen, J., & Irvine, D. J. (2009) · Biomacromolecules · doi:10.1021/bm801199z · Cited by 72
Self-citationWiig, H., Gyenge, C. C., Iversen, P. O., Gullberg, D., & Tenstad, O. (2008) · Microcirculation · doi:10.1080/10739680701671105 · Cited by 72
Schliehe, C., Redaelli, C., Engelhardt, S., Fehlings, M. G., Mueller, M., van Rooijen, N., Thiry, M., Hildner, K. M., Weller‡, H., & Groettrup, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002084 · Cited by 66
Deliberately provoking local inflammation drives tumors to become their own protective vaccine site
Jackaman, C., Lew, A. M., Zhan, Y., Allan, J. E., Koloska, B., Graham, P. T., Robinson, B. W. S., & Nelson, D. J. (2008) · International Immunology · doi:10.1093/intimm/dxn104 · Cited by 66
Liao, D., Liu, Z., Wrasidlo, W., Luo, Y., Nguyen, G., Chen, T., Xiang, R., & Reisfeld, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1264 · Cited by 64
Antigen Release Kinetics in the Phagosome Are Critical to Cross-Presentation Efficiency
Howland, S. W., & Wittrup, K. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1576 · Cited by 55
The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles
Malyala, P., Chesko, J., Ugozzoli, M., Goodsell, A., Zhou, F., Vajdy, M., O’Hagan, D. T., & Singh, M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21065 · Cited by 52
Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly
Pham, N.-L. L., Pewe, L. L., Fleenor, C. J., Langlois, R. A., Legge, K. L., Badovinac, V. P., & Harty, J. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004661107 · Cited by 52
Molavi, O., Mahmud, A., Hamdy, S. I., Hung, R., Lai, R. L., Samuel, J., & Lavasanifar, A. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900145g · Cited by 48
Tham, E. L., Jensen, P. L., & Mescher, M. F. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00335-5 · Cited by 47
CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer
Hellström, I., Ledbetter, J. A., Scholler, N., Yang, Y., Ye, Z., Goodman, G. E., Pullman, J., Hayden-Ledbetter, M. S., & Hellström, K. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.021557498 · Cited by 44
Landmark approval for Dendreon's cancer vaccine
DeFrancesco, L. (2010) · Nature Biotechnology · doi:10.1038/nbt0610-531 · Cited by 44
Pathogenic Role of B Cells in Anti-CD40-Induced Necroinflammatory Liver Disease
Kimura, K., Moriwaki, H., Nagaki, M., Saio, M., Nakamoto, Y., Naito, M., Kuwata, K., & Chisari, F. V. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050314 · Cited by 34
Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic
Tai, W., Roberts, L., Seryshev, A. B., Gubatan, J. M. B., Bland, C., Zabriskie, R. C., Kulkarni, S., Soong, L., Mbawuike, I. N., Gilbert, B. E., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.50 · Cited by 34
Fahmy, T. M., Schneck, J. P., & Saltzman, W. M. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.11.010 · Cited by 29
Synthetic CD4+ T Cell–Targeted Antigen-Presenting Cells Elicit Protective Antitumor Responses
Caserta, S., Alessi, P., Guarnerio, J., Basso, V., & Mondino, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5796 · Cited by 23
Immunologically Active Biomaterials for Cancer Therapy
Ali, O. A., & Mooney, D. J. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_69 · Cited by 15
Yellayi, S., Hilliard, B. A., Ghazanfar, M., Tsingalia, A., Nantz, M. H., Bollinger, L., de Kok-Mercado, F., & Hecker, J. G. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2002413 · Cited by 8
Cited by
Delivery technologies for cancer immunotherapy
Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,607
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Self-citationOsteoimmunomodulation for the development of advanced bone biomaterials
Chen, Z., Klein, T., Murray, R. Z., Crawford, R., Chang, J., Wu, C., & Xiao, Y. (2016) · Materials Today · doi:10.1016/j.mattod.2015.11.004 · Cited by 730
Metadata
- Authors
- Moon, J. J., Huang, B., & Irvine, D. J.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2012-05-29
- Volume
- 24
- Issue
- 28
- Pages
- 3724-3746
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W1598010923
- Cited by
- 404
- References
- 185
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.